New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
08:42 EDTSTJ
theflyonthewall.com: St. Jude Medical initiated with a Neutral at Wedbush
Target $35. :theflyonthewall.com



News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
There are 14 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2010
09:00 EDTSTJ
theflyonthewall.com: On The Fly: Analysts Downgrade Summary
MOST NOTEWORTHY: Dun & Bradstreet (DNB), Metro Bancorp (METR) and Airgas (ARG) were today's noteworthy downgrades: JP Morgan downgraded Dun & Bradstreet to Neutral from Overweight to reflect a lack of positive catalysts. The firm lowered its target price on shares to $80 from $87. Janney Montgomery downgraded Metro Bancorp to Neutral from Buy following the company's Q4 results and lowered its target price on shares to $14 from $20. Baird downgraded Airgas to Neutral from Outperform. The firm believes the proposed acquisition by Air Products (APD) will get done...OTHER DOWNGRADES: Petrohawk Energy (HK) was downgraded to Market Perform from Outperform at Bernstein. AMB Property (AMB) was lowered to Neutral from Outperform at Credit Suisse. St. Jude Medical (STJ) was downgraded to Conviction Sell from Sell at Goldman. :theflyonthewall.com
06:36 EDTSTJ
theflyonthewall.com: St. Jude Medical downgraded to Conviction Sell from Sell at Goldman
Target $35. :theflyonthewall.com

February 4, 2010
09:02 EDTSTJ
theflyonthewall.com: St. Jude Medical announces European approval of new heart failure monitors

Subscribe for More Information
:theflyonthewall.com

February 3, 2010
08:00 EDTSTJ
theflyonthewall.com: St. Jude Medical announces IRASE AF clinical trial
St. Jude Medical announced it has received an Investigational Device Exemption from the U.S. Food and Drug Administration to begin enrollment in the IRASE AF trial, a multicenter, randomized, single-blind study evaluating the safety and efficacy of the company’s Duo 12 port open irrigated catheter ablation system for treatment of Atrial Fibrillation. AF is the most common cardiac arrhythmia, affecting an estimated 3.3 million Americans and millions more worldwide. :theflyonthewall.com

February 2, 2010
12:57 EDTSTJ
theflyonthewall.com: St. Jude volatility low into analyst meeting and long-term growth outlook

Subscribe for More Information
:theflyonthewall.com
10:04 EDTSTJ
theflyonthewall.com: St. Jude Medical to host investor meeting

Subscribe for More Information
:theflyonthewall.com

January 28, 2010
07:45 EDTSTJ
theflyonthewall.com: St. Jude Medical mentioned positively at JP Morgan

Subscribe for More Information
:theflyonthewall.com

January 27, 2010
10:48 EDTSTJ
theflyonthewall.com: St. Jude Medical's bulllish outlook is intact, says JP Morgan

Subscribe for More Information
:theflyonthewall.com
09:21 EDTSTJ
theflyonthewall.com: St. Jude Medical: Total cardiovascular sales were $240M, up 10%

Subscribe for More Information
:theflyonthewall.com
09:20 EDTSTJ
theflyonthewall.com: St. Jude Medical: Q4 sales of neuromodulation products were $94M
St. Jude Medical sales of neuromodulation products were $94 million in the fourth quarter of 2009, up 21 percent from the comparable quarter of 2008 :theflyonthewall.com
09:19 EDTSTJ
theflyonthewall.com: St. Jude Medical: Q4 pacemaker sales were $303M, up 3%

Subscribe for More Information
:theflyonthewall.com
09:17 EDTSTJ
theflyonthewall.com: St. Jude Medical:Total Cardiac Rhythm Management sales were $698M, up 3%
Total Cardiac Rhythm Management sales, which include implantable cardioverter defibrillator-ICD-and pacemaker products, were $698 million for the fourth quarter of 2009, a 3 percent increase compared to the fourth quarter of 2008. After adjusting for the impact of foreign currency, total CRM sales decreased 1 percent. Total CRM product sales for the full-year 2009 were $2.769 billion, representing a 3 percent increase over 2008. On a currency neutral basis, total CRM sales grew 5 percent over the prior year :theflyonthewall.com
07:34 EDTSTJ
theflyonthewall.com: St. Jude Medical sees Q1 EPS 66c-68c vs. consensus s65c
Sees FY10 EPS $2.71-$2.76 vs. consensus $2.71. :theflyonthewall.com
07:33 EDTSTJ
theflyonthewall.com: St. Jude Medical reports Q4 EPS 64c vs. consensus of 62c

Subscribe for More Information
:theflyonthewall.com